Mortality data for Healthcare Analytics
August 25, 2025
Mortality is one of the most overlooked data signals in life sciences.
But when integrated thoughtfully, it transforms how we measure outcomes, validate cohorts, and monitor long-term safety.
Most real-world datasets don’t capture mortality by default. And when they do, it’s often incomplete, delayed, or disconnected.
That’s changing.
We’re seeing curated approaches that link multiple sources: public, administrative, payer-derived; into structured death flags along with cause of death
Why it matters:
- HEOR: Better survival curves and real-world outcomes
- Safety: Clarity on treatment-related mortality
- Trial design: Validated endpoints for feasibility and synthetic control arms
- Commercial: Improved triangulation and patient journey closure
The real shift is treating mortality as a primary signal; not an afterthought.
Curious how others are integrating this layer, and what it’s unlocking across functions.
#RWE #DataStrategy #ClinicalOutcomes #PharmaAnalytics #RealWorldEvidence